Latest news
Search news stories
Enter a keyword to search news.
Switching off “jumping genes” to outsmart resistant breast cancer
Breast cancer is the most commonly diagnosed cancer among women in Australia, with more than 21,000 new cases each year. Around 70 per cent of these cancers are oestrogen receptor–positive (ER+), a type that often responds well to hormone-based treatments.
[Read more about Switching off “jumping genes” to outsmart resistant breast cancer]
Global engagement in action: Suzanne’s research exchange sparks future collaborations
Suzanne Rajesh, a PhD student in the Prostate Cancer Research Group at the South Australian immunoGENomics Cancer Institute (SAiGENCI), is advancing the search for new biomarkers in prostate cancer through international collaboration.
